Digger, The new name for the new amalgamated company will be Microbot Medical Inc unless they come up with a different one. Microbot is taking over Stem to gain access to a Nasdaq listing, the exchange where Stem is already listed. So, yes, you are correct. I'm dumping my shares this morning as I read 2 Seeking Alpha stories last night saying Stem is not a recommended buy.
That is wrong. Microbot is essentially buying the shell from STEM, which will go private. STEM share holders will get 5% of the new shares. Assuming a similar number of shares Outstanding, at the time of merger, that's 50 new company shares for every 1000 held. Microbot has less than 10 employees they have developed some products but sold few at this point. Their valuation is likely quite low.
News 
Market Data 
Discover 
